CSS
BLU

Cubist Systematic Strategies’s BELLUS Health Inc. BLU Stock Holding History

Cubist Systematic Strategies’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-74,819
Closed -$614K – 4684
2022
Q4 		$614K Sell
74,819
-120,044
-62% -$1.12M ﹤0.01% 2878
2022
Q3 		$2.06M Buy
194,863
+147,364
+310% +$1.57M 0.01% 1986
2022
Q2 		$439K Sell
47,499
-24,209
-34% -$198K ﹤0.01% 3158
2022
Q1 		$493K Sell
71,708
-50,662
-41% -$326K ﹤0.01% 2546
2021
Q4 		$985K Buy
122,370
+109,152
+826% +$724K 0.01% 1929
2021
Q3 		$81K Sell
13,218
-6,840
-34% -$25.9K ﹤0.01% 2780
2021
Q2 		$62K Hold
20,058
– – ﹤0.01% 2767
2021
Q1 		$77K Hold
20,058
– – ﹤0.01% 2687
2020
Q4 		$61K Sell
20,058
-2,800
-12% -$7.59K ﹤0.01% 2452
2020
Q3 		$52K Sell
22,858
-6,848
-23% -$19.4K ﹤0.01% 2362
2020
Q2 		$306K Buy
+29,706
New +$301K 0.01% 1842
2019
Q4 		– Sell
-3,787
Closed -$24K – 2598
2019
Q3 		$24K Buy
+3,787
New +$26.7K ﹤0.01% 2111

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cubist Systematic Strategies's BLU Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of BELLUS Health Inc. (BLU) in Q1 2023, closing a stake of 74,819 shares — an estimated $614K sold.

Cubist Systematic Strategies first reported a position in BLU in Q3 2019 and held it in 12 quarters. The position peaked at $2.06M in Q3 2022. 106 funds tracked by Wall St. Rank hold BLU as of Q1 2023.

  • Cubist Systematic Strategies reported no remaining BELLUS Health Inc. position as of Q1 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 74,819 BELLUS Health Inc. shares in Q1 2023, an estimated $614K.
  • Cubist Systematic Strategies first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 12 quarters.
  • Cubist Systematic Strategies's BELLUS Health Inc. position peaked at $2.06M in Q3 2022.
  • 106 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.